Search research articles
Contact Us
Filters
Showing results (101-110 of 115) with videos related to
Page
of 12
Sort By:
Cancer Research
|
August 21, 2023
DNA Methylation-Based Testing in Peripheral Blood Mononuclear Cells Enables Accurate and Early Detection of Colorectal Cancer
Yan Xie, Peilong Li, Dong Sun, et al.
The CRISPR Journal
|
February 22, 2021
Development and Characterization of a Modular CRISPR and RNA Aptamer Mediated Base Editing System
Juan Carlos Collantes, Victor M Tan, Huiting Xu, et al.
Clinical and Translational Science
|
November 29, 2024
Pharmacokinetics of infigratinib and its active metabolites in Chinese patients with advanced gastric cancer harboring FGFR2 gene amplification
Jiajia Yuan, Lin Shen, Tian Shu Liu, et al.
Frontiers in Oncology
|
October 5, 2020
Expert Consensus for Treating Cancer Patients During the Pandemic of SARS-CoV-2
Shuang Dong, Chenggang Luo, Xuebo Hu, et al.
International Journal of Surgery (London, England)
|
October 1, 2024
Multisite DNA methylation alterations of peripheral blood mononuclear cells serve as novel biomarkers for the diagnosis of AIS/stage I lung adenocarcinoma: a multicenter cohort study
Peilong Li, Shibiao Liu, Tiantian Wang, et al.
BMJ (Clinical Research Ed.)
|
March 12, 2026
Camrelizumab plus CAPOX with camrelizumab based maintenance versus CAPOX alone as initial treatment for gastric or gastro-oesophageal junction adenocarcinoma: randomised phase 3 trial
Zhi Peng, Yanqiao Zhang, Huiting Xu, et al.
BMC Cancer
|
August 31, 2024
Characteristics and patient-reported outcomes of long-term cancer survivors after apatinib-based therapy: an online survey
Tingting Zhang, Chao Meng, Wei He, et al.
Nature Medicine
|
April 10, 2025
Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1/2 and phase 2 trials
Shen Zhao, Ying Cheng, Qiming Wang, et al.
Cancer Cell
|
October 24, 2025
TROP-2-targeted antibody-drug conjugate SHR-A1921 for advanced or metastatic solid tumors: A first-in-human phase 1 study
Jia Zhong, Lin Wu, Zhengbo Song, et al.
Experimental Hematology & Oncology
|
November 22, 2025
Development and clinical trial of M701, an Anti-EpCAM × Anti-CD3 bispecific antibody: a targeted intraperitoneal therapy for malignant ascites stemming from advanced solid tumors
Rongrui Liu, Rongbo Lin, Ning Li, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 115) with videos related to
Sort By:
Page
of 12
Cancer Research
|
August 21, 2023
DNA Methylation-Based Testing in Peripheral Blood Mononuclear Cells Enables Accurate and Early Detection of Colorectal Cancer
Yan Xie, Peilong Li, Dong Sun, et al.
The CRISPR Journal
|
February 22, 2021
Development and Characterization of a Modular CRISPR and RNA Aptamer Mediated Base Editing System
Juan Carlos Collantes, Victor M Tan, Huiting Xu, et al.
Clinical and Translational Science
|
November 29, 2024
Pharmacokinetics of infigratinib and its active metabolites in Chinese patients with advanced gastric cancer harboring FGFR2 gene amplification
Jiajia Yuan, Lin Shen, Tian Shu Liu, et al.
Frontiers in Oncology
|
October 5, 2020
Expert Consensus for Treating Cancer Patients During the Pandemic of SARS-CoV-2
Shuang Dong, Chenggang Luo, Xuebo Hu, et al.
International Journal of Surgery (London, England)
|
October 1, 2024
Multisite DNA methylation alterations of peripheral blood mononuclear cells serve as novel biomarkers for the diagnosis of AIS/stage I lung adenocarcinoma: a multicenter cohort study
Peilong Li, Shibiao Liu, Tiantian Wang, et al.
BMJ (Clinical Research Ed.)
|
March 12, 2026
Camrelizumab plus CAPOX with camrelizumab based maintenance versus CAPOX alone as initial treatment for gastric or gastro-oesophageal junction adenocarcinoma: randomised phase 3 trial
Zhi Peng, Yanqiao Zhang, Huiting Xu, et al.
BMC Cancer
|
August 31, 2024
Characteristics and patient-reported outcomes of long-term cancer survivors after apatinib-based therapy: an online survey
Tingting Zhang, Chao Meng, Wei He, et al.
Nature Medicine
|
April 10, 2025
Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1/2 and phase 2 trials
Shen Zhao, Ying Cheng, Qiming Wang, et al.
Cancer Cell
|
October 24, 2025
TROP-2-targeted antibody-drug conjugate SHR-A1921 for advanced or metastatic solid tumors: A first-in-human phase 1 study
Jia Zhong, Lin Wu, Zhengbo Song, et al.
Experimental Hematology & Oncology
|
November 22, 2025
Development and clinical trial of M701, an Anti-EpCAM × Anti-CD3 bispecific antibody: a targeted intraperitoneal therapy for malignant ascites stemming from advanced solid tumors
Rongrui Liu, Rongbo Lin, Ning Li, et al.
Page
of 12